BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 20094653)

  • 1. Genome-scale metabolic network analysis and drug targeting of multi-drug resistant pathogen Acinetobacter baumannii AYE.
    Kim HU; Kim TY; Lee SY
    Mol Biosyst; 2010 Feb; 6(2):339-48. PubMed ID: 20094653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-scale modeling and in silico analysis of mouse cell metabolic network.
    Selvarasu S; Karimi IA; Ghim GH; Lee DY
    Mol Biosyst; 2010 Jan; 6(1):152-61. PubMed ID: 20024077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-scale analysis of Mannheimia succiniciproducens metabolism.
    Kim TY; Kim HU; Park JM; Song H; Kim JS; Lee SY
    Biotechnol Bioeng; 2007 Jul; 97(4):657-71. PubMed ID: 17405177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-resistant gene based genotyping for Acinetobacter baumannii in tracing epidemiological events and for clinical treatment within nosocomial settings.
    Jin H; Xu XM; Mi ZH; Mou Y; Liu P
    Chin Med J (Engl); 2009 Feb; 122(3):301-6. PubMed ID: 19236808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates.
    Antunes LC; Imperi F; Towner KJ; Visca P
    Res Microbiol; 2011 Apr; 162(3):279-84. PubMed ID: 21144895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting multiple targets in Pseudomonas aeruginosa PAO1 using flux balance analysis of a reconstructed genome-scale metabolic network.
    Perumal D; Samal A; Sakharkar KR; Sakharkar MK
    J Drug Target; 2011 Jan; 19(1):1-13. PubMed ID: 20233082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-scale reconstruction and in silico analysis of the Clostridium acetobutylicum ATCC 824 metabolic network.
    Lee J; Yun H; Feist AM; Palsson BØ; Lee SY
    Appl Microbiol Biotechnol; 2008 Oct; 80(5):849-62. PubMed ID: 18758767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of beta-ketoadipate pathway from multi-drug resistance bacterium, Acinetobacter baumannii DU202 by proteomic approach.
    Park SH; Kim JW; Yun SH; Leem SH; Kahng HY; Kim SI
    J Microbiol; 2006 Dec; 44(6):632-40. PubMed ID: 17205041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential genes on metabolic maps.
    Gerdes S; Edwards R; Kubal M; Fonstein M; Stevens R; Osterman A
    Curr Opin Biotechnol; 2006 Oct; 17(5):448-56. PubMed ID: 16978855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between antimicrobial resistance and aminoglycoside-modifying enzyme gene expressions in Acinetobacter baumannii.
    Shi WF; Jiang JP; Mi ZH
    Chin Med J (Engl); 2005 Jan; 118(2):141-5. PubMed ID: 15667800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting gene essentiality using genome-scale in silico models.
    Joyce AR; Palsson BØ
    Methods Mol Biol; 2008; 416():433-57. PubMed ID: 18392986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Observing local and global properties of metabolic pathways: 'load points' and 'choke points' in the metabolic networks.
    Rahman SA; Schomburg D
    Bioinformatics; 2006 Jul; 22(14):1767-74. PubMed ID: 16682421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting drug targets with minimum side effects in metabolic networks.
    Li Z; Wang RS; Zhang XS; Chen L
    IET Syst Biol; 2009 Nov; 3(6):523-33. PubMed ID: 19947778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive biomarkers for drug-resistant Acinetobacter baumannii isolates with bla(TEM-1), AmpC-type bla and integrase 1 genotypes.
    Chen CH; Young TG; Huang CC
    J Microbiol Immunol Infect; 2006 Oct; 39(5):372-9. PubMed ID: 17066198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transmission and molecular characteristics of carbapenem-resistant Acinetobacter baumannii].
    Wei X; Shen DX; Yan ZQ; Luo YP; Cao JR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Mar; 29(3):277-81. PubMed ID: 18788529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex.
    Lin L; Ling BD; Li XZ
    Int J Antimicrob Agents; 2009 Jan; 33(1):27-32. PubMed ID: 18790612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection of integron, homology and genotype of carbapenemases in multi-drug resistant Acinetobacter Baumannii isolated from burn wound].
    Jiang LY; Xue XD; Wei LH; Si XQ; Liu G; Zhou H; Yu YS
    Zhonghua Shao Shang Za Zhi; 2008 Dec; 24(6):432-6. PubMed ID: 19149944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.